Form 6-K NovaBridge Biosciences For: Oct 25
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of October 2026
Commission File Number: 001-39173
NovaBridge Biosciences
2440 Research Boulevard, Suite 400
Rockville, MD 20850
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
On October 25, 2026, NovaBridge Biosciences issued a press release, a copy of which is furnished herewith as Exhibit 99.1 to this report.
EXHIBIT INDEX
Exhibit No. |
Description |
|
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
NovaBridge Biosciences |
||
|
|
||
|
By |
: |
/s/ Kyler Lei |
|
Name |
: |
Kyler Lei |
|
Title |
: |
Chief Financial Officer |
Date: October 26, 2026
ATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NovaBridge reports Phase 1b givastomig data at ESMO 2026
- A World First, Beacon AI Flies Murdock Its AI Pilot Assistant System Aboard Operational USAF Tankers
- Ellucian Wins 2026 Stratus Award for Cloud Computing for Third Consecutive Year
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share